Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced performance ...

Building on the success of the Cologuard ® and Oncotype ® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis.

Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis.

Exact Sciences Corporation ( NASDAQ: EXAS) Wells Fargo 2024 Healthcare Conference September 5, 2024 3:45 PM ET ...

A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the ...

A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the succ ...

The obvious question is what makes one startup better than the other?An idea? No. An execution? Not exactly. The right place ...

Despite extensive studies, however, the exact mechanism of this process is ... paving the way for advanced carbon dioxide-absorbing building materials. Cement-based materials provide a potential ...

A team of archeologists in Egypt uncovered a sword with hieroglyphs showing the name of pharaoh Ramesses II. The weapon was ...

Tulane officials said they hope the latest gift will raise the public health school's profile. The U.S. News and World Report ...